![](https://investorshub.advfn.com/uicon/613762.png?cb=1495247035)
Thursday, September 13, 2018 8:35:05 PM
This indication, at the time of trial design was PSTI's highest opportunity of success. Higher than any other possible indications based on the MOA (mechanism of action) - mesenchymal stem cell activity, healing and regenerating - the 'promise' of stem cell treatment. CLI has the Highest chance of success for this MOA to demonstrate its most statistically significant effects. Literally, angiogenesis and vasculogenesis … growing new tissue, vessels, capillaries, in essence, re-birthing tissues, vasculature and limbs.
Now, re-read the primary investigators quotes, do you get the sense that this type of success is taking place in the trial????
And now... Study Changes and reaffirmation of 2020 as end of study. Think about it, read it for yourself.
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM